271 related articles for article (PubMed ID: 12890207)
1. An evaluation of the usefulness of mycophenolate mofetil in pemphigus.
Powell AM; Albert S; Al Fares S; Harman KE; Setterfield J; Bhogal B; Black MM
Br J Dermatol; 2003 Jul; 149(1):138-45. PubMed ID: 12890207
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.
Doukaki S; Platamone A; Alaimo R; Bongiorno MR
J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases.
Grundmann-Kollmann M; Korting HC; Behrens S; Kaskel P; Leiter U; Krähn G; Kerscher M; Peter RU
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):957-60. PubMed ID: 10365927
[TBL] [Abstract][Full Text] [Related]
4. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent.
Esmaili N; Chams-Davatchi C; Valikhani M; Farshidfar F; Parvaneh N; Tamizifar B
Eur J Dermatol; 2008; 18(2):159-64. PubMed ID: 18424375
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil as adjuvant in pemphigus vulgaris.
Sarma N; Ghosh S
Indian J Dermatol Venereol Leprol; 2007; 73(5):348-50. PubMed ID: 17921620
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil for the management of autoimmune bullous diseases.
Eskin-Schwartz M; David M; Mimouni D
Dermatol Clin; 2011 Oct; 29(4):555-9. PubMed ID: 21924997
[TBL] [Abstract][Full Text] [Related]
7. [Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris].
Chams-Davatchi C; Nonahal Azar R; Daneshpazooh M; Valikhani M; Hallaji Z; Barzegari M; Firouz AR; Zakeri M
Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):23-5. PubMed ID: 11937925
[TBL] [Abstract][Full Text] [Related]
8. Treatment of refractory blistering autoimmune diseases with mycophenolic acid.
Marzano AV; Dassoni F; Caputo R
J Dermatolog Treat; 2006; 17(6):370-6. PubMed ID: 17853312
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris.
Baskan EB; Yilmaz M; Tunali S; Saricaoglu H
J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1432-4. PubMed ID: 19470052
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil as an adjuvant therapy for classic and endemic pemphigus foliaceus.
Kawashita MY; Tsai K; Aoki V; Santi CG; Maruta CW; Rivitti E
J Dermatol; 2005 Jul; 32(7):574-80. PubMed ID: 16335874
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil in autoimmune and inflammatory skin disorders.
Nousari HC; Sragovich A; Kimyai-Asadi A; Orlinsky D; Anhalt GJ
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):265-8. PubMed ID: 10025760
[TBL] [Abstract][Full Text] [Related]
12. Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus.
Williams JV; Marks JG; Billingsley EM
Br J Dermatol; 2000 Mar; 142(3):506-8. PubMed ID: 10735959
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil as a first-line steroid-sparing agent in the treatment of pemphigus vulgaris.
Vyas N; Patel NS; Cohen GF
J Drugs Dermatol; 2013 Feb; 12(2):210-6. PubMed ID: 23377396
[TBL] [Abstract][Full Text] [Related]
14. [IgA pemphigus. Successful treatment with mycophenolate mofetil].
Burchardt T; Büchau A; Ruzicka T; Megahed M
Hautarzt; 2004 Apr; 55(4):387-9. PubMed ID: 15021936
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate is effective in the treatment of pemphigus vulgaris.
Enk AH; Knop J
Arch Dermatol; 1999 Jan; 135(1):54-6. PubMed ID: 9923781
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
Orth T; Peters M; Schlaak JF; Krummenauer F; Wanitschke R; Mayet WJ; Galle PR; Neurath MF
Am J Gastroenterol; 2000 May; 95(5):1201-7. PubMed ID: 10811328
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic evaluation of mycophenolate mofetil for pemphigus.
Doukaki S; Pistone G; Aricò M; Bongiorno MR
Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):237-44. PubMed ID: 21192770
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.
Chams-Davatchi C; Esmaili N; Daneshpazhooh M; Valikhani M; Balighi K; Hallaji Z; Barzegari M; Akhyani M; Ghodsi SZ; Seirafi H; Nazemi MJ; Mortazavi H; Mirshams-Shahshahani M
J Am Acad Dermatol; 2007 Oct; 57(4):622-8. PubMed ID: 17583373
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of mycophenolate mofetil as a steroid-sparing agent in pemphigus: a randomized, prospective study.
Ioannides D; Apalla Z; Lazaridou E; Rigopoulos D
J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):855-60. PubMed ID: 21752101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]